Serbian opposition lawmakers threw smoke grenades and tear gas inside parliament on Tuesday to protest against the government ...

Notably, off-label tenecteplase had already become the preferred thrombolytic for acute ischemic stroke before the expanded ...

Women with one or more gynecological disorders had higher risk of heart disease and clogged arteries affecting either their ...

Popovich has not coached since suffering what the Spurs described as a “mild stroke” on Nov. 2. His status for next season is ...

For patients with acute ischemic stroke (AIS) whose symptoms began 4.5 to 24 hours earlier, alteplase is associated with a higher percentage of patients achieving a score of 0 or 1 on the modified ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

A new Georgetown University Medical Center study exploring a new brain imaging technique is bringing stroke experts a step ...

San Antonio Spurs coach Gregg Popovich announces he will not return to the sidelines this season after he suffered a mild ...

In 2023, Roche said it was removing TNKase for stroke from its phase 3 programmes after a readout of the TIMELESS trial, but ...

Discover how hypertension, diabetes, atrial fibrillation, high cholesterol, and obesity increase stroke risk, and learn ...

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

A molecule called glial fibrillary acidic protein (GFAP) rose significantly in the blood of patients who underwent ...